Laurus Infosystems unveils 'Chemia', its cost-effective Electronic Notebook for research labs in India
Laurus Infosystems, one of the leading software solution providers to the life sciences industry has now displayed Chemia, a user friendly and cost-effective Electronic Lab Notebook (ELN) at an official product launch to the science and technology community in India.
Chemia is revolutionary ELN product that will contribute hugely in helping research scientists and labs become more efficient. It will help manage projects effectively and protects the intellectual property of the organisation. Furthermore, the application helps users in quickly searching, retrieving and analysing the experiments and streamlining the workflows.
The presentation was held in collaboration with Laurus Labs, a leading active pharmaceutical ingredient manufacturer at Hyderabad. During the event which attracted officials from the life sciences and pharmaceutical industries provided an opportunity to understand the implementation of an Electronic Laboratory Notebook used in increasing efficiency at Research & Development (R&D) laboratories.
“Chemia is a chemist-driven ELN, focused on helping chemists to streamline their work and improve speed and compliance,” said Dr Satyanarayana Chava, chief executive officer, Laurus Labs Pvt. Ltd.
The layout of Chemia is easy-to-understand and quickly adoptable by the user, informed Priya Ranjan Belwariar, president, Laurus Infosystems.
According to Chandrekanth Cherredi, head, Project Management, Laurus Labs, Chemia is the ideal solution to improve efficiency, effectiveness and quality of research of chemistry R&D set ups. Whether the system is used by 10, 100 or 1000 scientists, the ELN provides organisations of any size a high return on investment and excellent value for money.
Laurus Infosystems, a division of Laurus Labs Private Limited, is a CMMi Level 3 organisation that has over 16 years of experience in providing solutions to some of the largest pharmaceutical companies globally.
Laurus Labs with multiple manufacturing sites is audited by US FDA, TGA and MHRA. It has capabilities in a wide range of areas including high potent molecules. The company is using its expertise in process chemistry to set new standards in competitive supply of high quality materials. It has also obtained CEPs from EDQM for several molecules. Now the company is embarking on a capacity expansion plan that will see it become one of the largest manufacturing units in India within the next 24 months.